At Renauxe, we are driven by our passion to develop innovative cutting edge therapies in super speciality domain. We have earned the trust of patients and doctors through our products that are safe, efficacious and affordable. We are constantly engaged in pursuit of excellence to find solutions that completely heal our country and the entire world.
Renauxe Pharma India Private Limited, is India's upcoming super specialty and innovation-led pharmaceutical company, committed to reduce therapy costs of chronic diseases like Chronic Kidney Diseases, autoimmune, diabetes, Cardiovascular diseases to name a few.
With major Product portfolio covers from Mycophenolate Mofetil, Tacrolimus, Sirolimus, prophylactic immunosuppressives for Organ Transplant, to adjuvant care medicines in dialysis like, Alpha Keto Analogue, Pre Probiotic, Sodium Bicarbonate, Calcitriol, Calcium Acetate, EPA-DHA.
Antihypertensives ranges from , Clonidine Hcl, Prasozin Hcl SR, to ARBs and its commbinations. Urology portfolio covers from Tamsulosin, Dutastride, Sodabicarb, Potassium Magnesium Citrate with Vitamin B6 to Febuxostat.
Nefropres C-150 tab and Scribnor-25 Cap are the lone brands in the country to its monopoly and Acidose, the leading sodium bicarbonate brand.
Some of our important products in urology include:
Some of our highlights:
Besides, we are committed towards disease detection and patient awareness programmes like ‘Check Your BP’ which can help doctors reach hundreds of undiagnosed patients and improve patient care and treatment adherence.
In the years to come, we shall continue to introduce novel drugs and combinations.